文献速递生殖医学母胎医学

卵母细胞玻璃化对高龄患者染色体非整倍体模式及卵母细胞复原力的影响

Impact of oocyte vitrification on chromosome-specific aneuploidy patterns and oocyte resilience in advanced maternal age patients.
PubMed 文献 · Reprod Biomed Online · 2026-06-29

本研究纳入122例高龄患者的441枚新鲜与343枚玻璃化卵母细胞,比较其来源囊胚的染色体非整倍体分布。玻璃化未改变整体或染色体特异性非整倍体模式及年龄相关动态,但每枚受精MII卵的整倍体囊胚率显著降低,提示卵母细胞复原力下降。

要点

  • 玻璃化不改变高龄患者囊胚整体或染色体特异性非整倍体分布。
  • 玻璃化使每枚受精MII卵的整倍体囊胚率显著降低。
  • 年龄相关非整倍体趋势在新鲜与玻璃化组间相似。

核心结论

  • 卵母细胞玻璃化不显著改变高龄女性囊胚的整条染色体非整倍体模式。
  • 玻璃化降低卵母细胞复原力,主要影响发育潜能。

研究设计与样本

  • 观察性研究纳入122例高龄患者,比较同一患者来源的441枚新鲜与343枚玻璃化卵母细胞所获163枚非整倍体囊胚。
  • 通过热图和森林图比较染色体特异性非整倍体分布及年龄相关模式,回归分析评估年龄依赖的整倍体趋势。
  • 以每枚受精MII卵获得的整倍体囊胚数作为卵母细胞对玻璃化复原力的指标。

主要发现

  • 两队列整倍体率均随母亲年龄增加而下降,回归斜率相近。
  • 玻璃化未改变整体或染色体特异性非整倍体分布及其年龄相关动态。
  • 经典年龄相关错误染色体(16、22、21、15、18和13)在两组中呈现相似的年龄依赖特征。
  • 玻璃化组每枚受精MII卵的整倍体囊胚率显著低于新鲜组,提示发育能力降低。

临床怎么用

  • 解读高龄患者PGT-A结果时,玻璃化不影响非整倍体模式,但需注意整倍体囊胚率可能降低。
  • 个性化IVF治疗中,玻璃化卵母细胞应关注发育潜能下降对每周期整倍体囊胚获得数的影响。

局限性

  • 研究为观察性设计,且仅纳入非整倍体囊胚进行分析。
  • 样本来自单中心接受卵母细胞累积的高龄患者,结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: Does oocyte vitrification affect chromosome-specific and age-dependent aneuploidy patterns in blastocysts from women of advanced maternal age? DESIGN: This observational study included 163 aneuploid blastocysts derived from 441 fresh and 343 vitrified-warmed oocytes obtained from 122 patients of advanced maternal age undergoing oocyte accumulation for preimplantation genetic testing for aneuploidies (PGT-A). The blastocysts were compared based on whether they were derived from fresh or vitrified-warmed oocytes, obtained from the same patients. Chromosome-specific aneuploidy distributions were compared and age-related patterns were assessed by heatmap visualization and forest plot analyses. Age-dependent euploidy trends were evaluated by regression analysis. The number of euploid blastocysts obtained per inseminated metaphase II (MII) oocyte was calculated as an indicator of oocyte resilience to vitrification. RESULTS: Euploidy rates declined with increasing maternal age in both cohorts, with comparable regression slopes between fresh and vitrified-warmed oocytes. Oocyte vitrification did not alter the global or chromosome-specific distribution of aneuploidies or their age-related dynamics. Chromosomes classically associated with age-dependent errors (16, 22, 21, 15, 18 and 13) showed similar age-dependent profiles in both cohorts. Despite preserved chromosomal stability, vitrified-warmed oocytes exhibited a significantly lower euploid blastocyst rate per inseminated MII oocyte, indicating reduced developmental competence. CONCLUSIONS: Oocyte vitrification does not substantially alter the patterns of whole-chromosome aneuploidy in blastocysts from women of advanced maternal age. However, vitrification reduces oocyte resilience, mainly affecting developmental competence. Integrating chromosome-specific analyses, a refined framework was provided for interpreting PGT-A outcomes and personalizing IVF treatments in advanced maternal age patients.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Canosa S, Ottolini CS, Capalbo A, et al. Impact of oocyte vitrification on chromosome-specific aneuploidy patterns and oocyte resilience in advanced maternal age patients. Reprod Biomed Online. 2026. PMID: 42561479. doi:10.1016/j.rbmo.2026.105841

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。